pregnant women

3 alpha Hydroxy 5 alpha pregnan 20 one

It is used for pregnant women to be found and sows. It has anesthetic, hypnotic and sedative properties.

4 Amino 1 Hydroxybutylidene 1, 1 Biphosphoneate

It is used for women while meno paus, A nonhormonal medication for the treatment of postmenopausal osteporosisin in women. This drug builds healthy bone,restoring some of the bone loss as a result of osteporosis

vitamin tablet

one alpha, 25 Dihydroxyvitamin D3

It is Physiologically active form of Vitamin D. It is to be formed by primarily in the kidney by Enzymatic Hydroxylation of 25 Hydroxycholecalcieron. Its productionis stimulated by low blood calcium levels and parathyroid hormone. Calcitrol increases intestinal absorption of Calcium and Phosphrous, and it is to be cosult with doctor parathyroid hormone increases bone resorption.

Health secret Cardiovascular

Samurai Warriors feasted on it and displayed bone crushing prowess on the battlefield. A Japanese Scientists rediscovered it, saving countless lives, its secret is now reemerging. It is well known that the Japanese enjoy a higher level of Cardivascular health than their Western counterparts.

The reason very well may be that the Japanese consume a large quanitity of products like soya beans that they call Nattokinase. Dr.Hiroyuki Sumi a Japanese reasearcher working at the university of CHICAGO'S Medical School in 1980's tested a total of 175 food substances including Nattokinase to find a natural clot dissolving enzyme. His results with Nattakinase were startling. Within 24 Hours, a drop of Nattlkinase placed on a laboratory blood clot broke up and open and blood pulsing through your arteries than many Medical Treatment. It appears to be 10% reduction of both diastolic and Systolic blood pressures.

Present Proton Therapy Centers

Proton therapy needs heavy equipment. For instance, the Orsay proton therapy center, in France, (see figure) uses a synchrocyclotron weighing 900 tons in total. Such equipment was formerly only available within centers studying particle physics. In the case of the Orsay installation, the treatment machine was converted from particle research usage to medical usage.

Presently (end of 2008), there are proton therapy centers in Canada, China, England, France, Germany, Italy, Japan (5 centers), Korea, Russia, South Africa, Sweden, Switzerland, and USA (6 centers), altogether 26 installations, and over 60000 patients have been treated so far.

Proton therapy for ocular tumors is a special case since this treatment requires only a comparably low energy (about 70 MeV). In the United Kingdom, it is currently only available at the Clatterbridge Centre for Oncology in Bebington on the Wirral, Merseyside. In the USA, it is available in Sacramento, California at the University of California, Davis, , the UC Davis Proton Facility which is operated exclusively by the UC San Francisco Department of Radiation Oncology. Since 2004, the Midwest Proton Radiotherapy Institute at Indian University, and, in 2006, the University of Texas M.D. Anderson Cancer Center in Houston TX, and the University of Florida Proton Therapy Institution, Jacksonville, Florida.

With over 5000 patients, the largest number of ocular tumors have been treated since 1984 at the Paul Scherrer Institute in Switzerland Im March, 2009, patient treatment has begun at the first commercial proton therapy center of Europe, the Rinecker Proton Therapy Center (RPTC) in Munich, Germany.

Skin cancer

Skin cancer is a malignant growth on the skin which can have many causes. The most common skin cancers are basal cell cancer, squamous cell cancer, and melanoma. Skin cancer generally develops in the epidermis (the outermost layer of skin), so a tumor is usually clearly visible. This makes most skin cancers detectable in the early stages. There are three common types of skin cancer, each of which is named after the type of skin cell from which it arises. Unlike many other cancers, including those originating in the lung, pancreas, and stomach, only a small minority of those afflicted will actually die of the disease.(citation needed) Skin cancers are the fastest growing type of cancer in the United States. Skin cancer represents the most commonly diagnosed malignancy, surpassing lung, breast, colorectal and prostate cancer. Melanoma is the least common skin cancer but it is potentially the most serious: there are over 8,000 new cases each year in the UK and 1,800 deaths. More people now die of Melanoma in the UK than in Australia. It is the second most common cancer in the young population (20 – 39 age group). It is estimated that approximately 85% of cases are caused by too much sun. Non-melanoma skin cancers are the most common skin cancers. The majority of these are called Basal Cell Carcinomas. These are usually localised growths caused by excessive cumulative exposure to the sun and do not tend to spread.

Colorectal cancer

Colorectal cancer, also called colon cancer or large bowel cancer, includes cancerous growths in the colon, rectum and appendix. With 655,000 deaths worldwide per year, it is the third most common form of cancer and the second leading cause of cancer-related death in the Western world.[1] Many colorectal cancers are thought to arise from adenomatous polyps in the colon. These mushroom-like growths are usually benign, but some may develop into cancer over time. The majority of the time, the diagnosis of localized colon cancer is through colonoscopy. Therapy is usually through surgery, which in many cases is followed by chemotherapy.

To Read More About This Article:http://en.wikipedia.org/wiki/Colon_cancer

Cancer

Cancer (medical term: malignant neoplasm) is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumors, which are self-limited, do not invade or metastasize. Most cancers form a tumor but some, like leukemia, do not. The branch of medicine concerned with the study, diagnosis, treatment, and prevention of cancer is oncology.

Cancer may affect people at all ages, even fetuses, but the risk for most varieties increases with age. Cancer causes about 13% of all deaths. According to the American Cancer society 7.6 million people died from cancer in the world during 2007. Cancers can affect all animals.

Nearly all cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation,chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may be randomly acquired through errors in DNA replication, or are inherited, and thus present in all cells from birth. The heritability of cancers are usually affected by complex interactions between carcinogens and the host's genome. New aspects of the genetics of cancer pathogenesis. DNA methylation, and microRNAs are increasingly recognized as important.

Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are typically activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are then inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system. Diagnosis usually requires the histologic examination of a tissue biopsy specimen by a pathologist, although the initial indication of malignancy can be symptoms or radiographic imaging abnormalities. Most cancers can be treated and some cured, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy, and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments.

Breast cancer

Breast cancer is a cancer that starts in the cells of the breat in women and men. Worldwide, breast cancer is the second most common type of cancer after lung cancer (10.4% of all cancer incidence, both sexes counted) and the fifth most common cause of cancer death. In 2005, breast cancer caused 502,000 deaths worldwide (7% of cancer deaths; almost 1% of all deaths).

Breast cancer also occurs in males. Incidences of breast cancer in men are approximately 100 times less common than in women, but men with breast cancer are considered to have the same statistical survival rates as women.

Brain tumor

A brain tumor (brain tumour in the UK and Canada; see spelling differences) is any intracranial tumor created by abnormal and uncontrolled cell division, normally either in the brain itself (neurons, glial cells(astrocytes,oligodendrocytes,ependymal cells), lymphatic tissue, blood vessels), in the cranial nerves (myelin-producing schwann cells), in the brain envelopes (meninges), skull, pituitary and pineal gland, or spread from cancers primarily located in other organs (metastatic tumors). Primary (true) brain tumors are commonly located in the posterior cranial fossa in children and in the anterior two-thirds of the cerebral hemispheres in adults, although they can affect any part of the brain. In the United States in the year 2005, it was estimated that there were 43,800 new cases of brain tumors (Central Brain Tumor Registry of the United States, Primary Brain Tumors in the United States, Statistical Report, 2005–2006), which accounted for 1.4 percent of all cancers, 2.4 percent of all cancer deaths, and 20–25 percent of pediatric cancers. Ultimately, it is estimated that there are 13,000 deaths per year in the United States alone as a result of brain tumors.

MESOTHELIOMA TREATMENTS

Malignant mesothelioma is an uncommon form of cancer typically associated with prolonged asbestos exposure. A rare yet serious disease, malignant mesothelioma attacks the mesothelium (membrane lining the heart sac and the lung and abdominal cavities), typically causing death within one to two years of diagnosis. Malignant mesothelioma types include:

Pleural Mesothelioma: The most common type of malignant mesothelioma, pleural mesothelioma attacks the thoracic cavity (lungs).

Peritoneal Mesothelioma: The second most common type of malignant mesothelioma, peritoneal
mesothelioma attacks the abdominal cavity (stomach).

Pericardial Mesothelioma: The least common type of malignant mesothelioma, pericardial mesothelioma attacks the heart sac.
A plethora of treatment options are available for the 2,000 to 3,000 cases of malignant mesothelioma diagnosed yearly throughout the United States.
Traditional Treatment Options There are three traditional ways to treat malignant mesothelioma:
Surgery
Chemotherapy
Radiation therapy (radiotherapy)
Doctors will often use a combination of two or more treatments (chemotherapy or radiotherapy is commonly used to stunt the growth of a malignant tumor prior to a surgical procedure).

Surgery: Surgical treatment of malignant mesothelioma is the physical removal of a cancerous tumor. The most proactive approach to treating any form of cancer, surgery is split into three categories:

Diagnostic surgery: A precursor to treatment rather than a method of treatment, diagnostic surgery helps confirm and stage malignant mesothelioma. In a procedure called a biopsy, tissue is removed from an area in question and examined by a pathologist.

Palliative surgery: As opposed to aggressively treating malignant mesothelioma, palliative surgery is the process of solely treating the disease's symptoms. For example, fluid build-up (pleural effusion) is a common symptom of malignant mesothelioma. Relief of pleural effusion requires draining of the fluid (thoracentesis). Because pleural effusion often recurs, the only way to eliminate the problem is through surgical closure of the pleural space.

Curative surgery: The goal of curative surgery is to remove all instances of malignant mesothelioma. More often than not, microscopic mesothelioma residue will remain following curative surgery, so it is typically followed by some other treatment (adjuvant therapy) such as chemotherapy or radiotherapy.

Chemotherapy: Treatment of mesothelioma using chemical substances is commonly referred to as chemotherapy. Cancer cells divide at a faster rate than normal cells, fostering a rapid spread of the disease. Although chemotherapy is not a curative procedure, it works to slow the spread of cancer cells throughout the body. Chemotherapy is used for various purposes in treating malignant mesothelioma:
Slowing the growth and spread of cancer cells throughout the body.
Shrinking tumors prior to surgical treatment (neoadjuvant chemotherapy).
Killing microscopic mesothelioma residue following surgery (adjuvant chemotherapy).
Treating the symptoms, using chemical substances (palliative chemotherapy).
Cisplatin has been used in the treatment of cancers since the 1970s when studies demonstrated its effectiveness in combating various sarcomas implanted in rats. A platinum-based chemotherapy drug, cisplatin is currently used for the treatment of sarcomas, carcinomas, lymphomas and germ cell tumors. Cisplatin was the first of a group of platinum-based chemotherapy drugs that now includes carboplatin and oxaliplatin. Although a traditional chemotherapy drug, cisplatin is often used in conjunction with various new treatment modalities or chemotherapy drugs. Both cisplatin and carboplatin are being tested in conjunction with pemetrexed (Alimta) for the treatment of malignant mesothelioma.

Radiation Therapy: Commonly called radiotherapy, radiation therapy uses high-energy rays such as x-rays to kill malignant mesothelioma cells. Somewhat similar to chemotherapy, radiotherapy is not typically viewed as a curative procedure; rather, it is used in combination with surgical procedures and for the purpose of treating the symptoms. Usually, radiotherapy is applied solely to a localized area of concern, as opposed to the entire body.